Nkarta (NKTX) Accumulated Expenses (2019 - 2026)
Nkarta's quarterly Accumulated Expenses came in at $9.5 million in Q1 2026, down 15.69% year-on-year from $11.3 million in Q1 2025, and down 28.21% quarter-over-quarter from $13.3 million in Q4 2025.
Nkarta has reported Accumulated Expenses for 8 years, with the latest figure at $9.5 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses fell 15.69% year-over-year to $9.5 million; the trailing twelve-month figure through Mar 2026 stood at $9.5 million (down 15.69% YoY), and the FY2025 full-year result was $13.3 million, up 8.66% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $9.5 million, down from $13.3 million in the prior quarter.
- The five-year high for Accumulated Expenses was $17.6 million in Q2 2023, with the low at $6.3 million in Q1 2022.
- Average Accumulated Expenses over 5 years is $12.3 million, with a median of $12.2 million recorded in 2024.
- Year-over-year, Accumulated Expenses surged 145.67% in 2023 and slumped 34.11% in 2024.
- Tracing NKTX's Accumulated Expenses over 5 years: stood at $16.0 million in 2022, then retreated by 15.22% to $13.6 million in 2023, then retreated by 10.05% to $12.2 million in 2024, then climbed by 8.66% to $13.3 million in 2025, then retreated by 28.21% to $9.5 million in 2026.
- The last three Accumulated Expenses figures came in at $9.5 million (Q1 2026), $13.3 million (Q4 2025), and $11.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Nkarta | 232.80 Mn | 232.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.54 Mn |
| Dec 31, 2025 | 13.29 Mn |
| Sep 30, 2025 | 11.18 Mn |
| Jun 30, 2025 | 10.51 Mn |
| Mar 31, 2025 | 11.32 Mn |
| Dec 31, 2024 | 12.23 Mn |
| Sep 30, 2024 | 13.78 Mn |
| Jun 30, 2024 | 11.57 Mn |
| Mar 31, 2024 | 12.93 Mn |
| Dec 31, 2023 | 13.60 Mn |
| Sep 30, 2023 | 15.30 Mn |
| Jun 30, 2023 | 17.55 Mn |
| Mar 31, 2023 | 14.82 Mn |
| Dec 31, 2022 | 16.04 Mn |
| Sep 30, 2022 | 11.57 Mn |
| Jun 30, 2022 | 7.15 Mn |
| Mar 31, 2022 | 6.32 Mn |
| Dec 31, 2021 | 9.35 Mn |
| Sep 30, 2021 | 7.45 Mn |
| Jun 30, 2021 | 5.81 Mn |
| Mar 31, 2021 | 5.19 Mn |
| Dec 31, 2020 | 6.25 Mn |
| Sep 30, 2020 | 5.82 Mn |
| Jun 30, 2020 | 4.60 Mn |
| Dec 31, 2019 | 3.29 Mn |